Michael Scolaro

Michael Scolaro

Sep 23, 2017

Group 6 Copy 254
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Development of non-invasive diagnostics for endotheliotropic herpesvirus in free-ranging Asian elephants

    Elephant endotheliotropic herpes virus hemorrhagic disease (EEHV-HD) is the leading cause of death of young...

    Antibiotics and Affect: Avenues for Addiction Management

    Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

    Help us pioneer stem cell therapy for giraffe!

    Arthritis is common in geriatric giraffe. Cheyenne Mountain Zoo is uniquely suited to help find better arthritis...

    Backer Badge Funded